Latest Blog


The MMRF continues to help push research forward

Post in Inspirational

The Multiple Myeloma Research Foundation and GNS Healthcare Announce Collaboration to Identify Potential New Multiple Myeloma Therapies CAMBRIDGE, Mass. & NORWALK, Conn.–(BUSINESS WIRE)–GNS Healthcare (GNS), a leading provider of analytics solutions for driving personalized interventions that improve population health, and the Multiple Myeloma Research Foundation (MMRF), a leader in accelerating the development of breakthrough multiple […]


Could ImMucin be the ultimate Immunotherapy?

Post in Research

Cancer Vaccine ImMucin Shows Promising Results After Clinical Trial; May Work On 90% Of All Cancer Types Researchers in Israel have taken a truly innovative approach toward treating cancer in their attempt to harness the body’s own immune system to fight off the disease. Based on clinical trials for a cancer vaccine, called ImMucin, results […]


If this works out a lot of us may live longer

Post in Research

Vitals Key clinical point: The investigational anti-CD38 antibodies SAR650984 and daratumumab in combination with standard regimens were highly active in untreated and relapsed/refractory multiple myeloma. Major finding: Overall response rates were 58% in patients treated with SAR650984, and 100% and 50%, respectively, in newly diagnosed and relapsed patients given daratumumab. Data source: Two phase Ib studies in […]